aXichem AB
- Jurisdiction
Sweden - LEI
549300REE3038LIBWS21 - ISIN
SE0005250719 (AXIC-A.ST )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. Read full profile
Fundamentals
- Net revenue
€998.43K - Gross margin
85.8% - EBIT
-€1.54M - EBIT margin
-154.3% - Net income
-€1.65M - Net margin
-164.8%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions